With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide - Fierce Pharma
With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide - Fierce Pharma
With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide - Fierce Pharma
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.